Adeona Pharmaceuticals

Synthetics Biologics

Adeona Becomes Synthetic Biologics, Inc.

Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had received shareholder approval to change its corporate name to Synthetic Biologics Inc.

WWJ Newsradio 950–02/16/2012

HR Notices From February 7

The latest staffing, boardroom and leadership changes at Michigan’s technology-focused companies and institutions

WWJ Newsradio 950–02/07/2012

adeona2

Adeona Names New Managers, Eyes Name Change

Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.

WWJ Newsradio 950–02/06/2012

adeona2

Adeona Reports Positive Study Results For Zinc Treatment Of ALS

Pharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig’s Disease

WWJ Newsradio 950–11/30/2011

HR Notices From November 2

The latest personnel, leadership and boardroom news from Michigan’s technology-focused companies and institutions

WWJ Newsradio 950–11/02/2011

adeona2

Chardan Capital Markets Initiates Research Coverage of Adeona

Adeona Pharmaceuticals Inc. (NYSE: AEN), announced Thursday that Chardan Capital Markets initiated independent equity research coverage of the company with a “Buy” rating and a 12-month price target of $1 per share.

WWJ Newsradio 950–10/27/2011

HR Notices From August 25

The latest personnel and boardroom announcements from Michigan’s technology-focused companies and institutions

WWJ Newsradio 950–08/25/2011

adeona2

Adeona Loss Grows, But Milestones Reached

Ann Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.

WWJ Newsradio 950–08/15/2011

adeona2

Ann Arbor Pharma To Offer New Cold Treatment

Ann Arbor-based Adeona Pharmaceuticals Inc. said it will commercialize an oral zinc lozenge as a homeopathic over-the-counter treatment for the common cold under the brand name wellZin.

WWJ Newsradio 950–07/28/2011

adeona

Adeona To Start New Trial Of Zinc-Based Therapy in Lou Gehrig’s Disease

Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) announced Thursday that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis also known as Lou Gehrig’s Disease.

WWJ Newsradio 950–06/23/2011

more

Follow

Get every new post delivered to your Inbox.

Join 1,975 other followers